Tag Archives: autologous

Personalized Medicines In A Serialized World

3d render of T cells attacking cancer cells

The era of personalized medicines has begun.  These are medicines that are tailored specifically for a single patient, using that patient’s specific DNA or other blood characteristic as a guide or actual source component.  The new chimeric antigen receptor T-cells (CAR-T) is an exciting example.  It results in the conversion of a patient’s own T-cells into cells that are able to recognize the specific type of cancer cells that the patient has, and thus able to attack them in the same way that normal T-cells attack normal infectious cells.  In short, it’s a way of manipulating a person’s own immune system to attack cancer cells that it would normally be blind to.  When it works, the results can be breathtaking.  The question is, how are these drugs treated under today’s serialization and tracing regulations?  Let’s take a look. Continue reading Personalized Medicines In A Serialized World